Therapeutic Solutions International Inc (TSOI)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Therapeutic Solutions International Inc (TSOI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011395
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Therapeutic Solutions International Inc (Therapeutic Solutions) is a pharmaceutical company that provides supplement products. The company offers ProJuvenol, T-Rx and Vital. Its ProJuvenol consists of anti-aging ingredients which helps for a healthy functionality for everyday living and promotes cellular rejuvenation. The company’s T-Rx is developed to increase the testosterone levels. Vital is an ati ageing vitalization dietary supplement which increases the bone density, optimize hormone levels for body shaping, reduce fat, improve muscle tone, increase libido and sexual function, and decrease symptoms of stress and anxiety. It markets its products through its sales offices in the US and abroad. Therapeutic Solutions is headquartered in Oceanside, California?, the US.

Therapeutic Solutions International Inc (TSOI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Therapeutic Solutions International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Therapeutic Solutions International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Therapeutic Solutions International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Therapeutic Solutions International Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Therapeutic Solutions International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Therapeutic Solutions International Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Therapeutic Solutions Acquires Preterm Labor and Miscarriage Intellectual Property from OmniBiome Therapeutics 10
Partnerships 11
OmniBiome Therapeutics Enters into Licensing Agreement with Therapeutic Solutions International for the Assessment of Pregnancy Complications 11
OmniBiome Therapeutics Enters into Licensing Agreement with Therapeutic Solutions International 12
Therapeutic Solutions International Enters into Licensing Agreement with Boyd Research and TMD Courses 13
Therapeutic Solutions Enters Into Distribution Agreement With S4S 14
Therapeutic Solutions Enters into Licensing Agreement with Boyd Research 15
Therapeutic Solutions International Inc – Key Competitors 16
Therapeutic Solutions International Inc – Key Employees 17
Therapeutic Solutions International Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Oct 17, 2017: Therapeutic Solutions International strengthens the TSOI Scientific Advisory Board with the Appointment of Pablo A. Guzman, MD 19
Product News 20
Apr 24, 2017: Therapeutic Solutions International’s Subsidiary OmniBiome Announces First Oral Microbiome Therapy for Periodontal Disease 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Therapeutic Solutions International Inc, Medical Equipment, Key Facts, 2016 2
Therapeutic Solutions International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Therapeutic Solutions International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Therapeutic Solutions International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Therapeutic Solutions International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Therapeutic Solutions International Inc, Deals By Market, 2011 to YTD 2017 8
Therapeutic Solutions International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Therapeutic Solutions Acquires Preterm Labor and Miscarriage Intellectual Property from OmniBiome Therapeutics 10
OmniBiome Therapeutics Enters into Licensing Agreement with Therapeutic Solutions International for the Assessment of Pregnancy Complications 11
OmniBiome Therapeutics Enters into Licensing Agreement with Therapeutic Solutions International 12
Therapeutic Solutions International Enters into Licensing Agreement with Boyd Research and TMD Courses 13
Therapeutic Solutions Enters Into Distribution Agreement With S4S 14
Therapeutic Solutions Enters into Licensing Agreement with Boyd Research 15
Therapeutic Solutions International Inc, Key Competitors 16
Therapeutic Solutions International Inc, Key Employees 17
Therapeutic Solutions International Inc, Subsidiaries 18

★海外企業調査レポート[Therapeutic Solutions International Inc (TSOI)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Le Chateau Inc. (CTU):企業の財務・戦略的SWOT分析
    Le Chateau Inc. (CTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BIND Therapeutics Inc (BIND)-製薬・医療分野:企業M&A・提携分析
    Summary BIND Therapeutics Inc (BIND Therapeutics) is a nanomedicine platform company that develops and commercializes preclinical candidates for cardiovascular disease, cancer and inflammatory disease. The company’s pipeline products include BIND-014, an Accurin that contains the well-established ch …
  • Shapoorji Pallonji & Co Pvt Ltd:企業の戦略的SWOT分析
    Shapoorji Pallonji & Co Pvt Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • ImmusanT Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ImmusanT Inc (ImmusanT) is a clinical stage biotechnology company that discovers, develops and delivers peptide-based immune therapies for the treatment of patients with autoimmune diseases. The company develops its therapeutic vaccines using its epitope-specific immuno-therapy (ESIT) platfo …
  • Cavitation Technologies Inc (CVAT):企業の財務・戦略的SWOT分析
    Summary Cavitation Technologies Inc (Cavitation) is an energy service company that develops processing technologies. The company processes fluidic mixtures, liquids, emulsions and suspended solids. Its technology uses hydrodynamic cavitation that comprise fluid’s vaporization and growth, pulsation, …
  • Turk Hava Yollari Anonim Ortakligi:企業の戦略・SWOT・財務情報
    Turk Hava Yollari Anonim Ortakligi - Strategy, SWOT and Corporate Finance Report Summary Turk Hava Yollari Anonim Ortakligi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Mincor Resources NL:企業の戦略・SWOT・財務情報
    Mincor Resources NL - Strategy, SWOT and Corporate Finance Report Summary Mincor Resources NL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Biocept Inc (BIOC):企業の財務・戦略的SWOT分析
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Intact Financial Corporation:戦略・SWOT・企業財務分析
    Intact Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Intact Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Viking Therapeutics Inc (VKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. The company’s lead clinical program product candidate include VK5211, an orally available, non-steroidal se …
  • Varta AG (VAR1):企業の財務・戦略的SWOT分析
    Varta AG (VAR1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Northwest Pipe Co (NWPX):企業の財務・戦略的SWOT分析
    Northwest Pipe Co (NWPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Actelion Ltd:企業の戦略・SWOT・財務分析
    Actelion Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sun Pharma Advanced Research Company Ltd (SPARC):製薬・医療:M&Aディール及び事業提携情報
    Summary Sun Pharma Advanced Research Company Ltd (SPARC), a subsidiary of Sun Pharmaceutical Industries Ltd, is a bio pharmaceutical clinical research and development service provider. The company develops active pharmaceutical ingredients, formulations and drug delivery technologies for the treatme …
  • Aldi Einkauf GmbH & Co oHG:企業の戦略・SWOT・財務情報
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mitsubishi International Food Ingredients, Inc.:戦略・SWOT・企業財務分析
    Mitsubishi International Food Ingredients, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi International Food Ingredients, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • DiaSorin SpA (DIA):企業の財務・戦略的SWOT分析
    DiaSorin SpA (DIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Kaiser Foundation Health Plan of Washington:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan of Washington - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • University of Strathclyde:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Strathclyde (Strathclyde) is an educational service provider that offers education, learning technologies and facilities. The university offers a wide range of undergraduate and postgraduate programs, and distance learning programs through its faculties of engineering, science, …
  • Fauji Fertilizer Bin Qasim Ltd (FFBL):企業の財務・戦略的SWOT分析
    Fauji Fertilizer Bin Qasim Ltd (FFBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆